Not losing weight on Mounjaro 2.5 mg? Here's why that's normal

The 2.5 mg dose: what your first pen is actually for

The Mounjaro prescribing schedule starts at 2.5 mg for one reason: to reduce the chance of nausea, vomiting and other gastrointestinal side effects that can occur when treatment begins. It is a settling-in period, not a treatment phase. Eli Lilly designed tirzepatide this way, and the NHS patient information for tirzepatide confirms that the dose is titrated gradually by the prescriber — the 2.5 mg pen's job is adjustment, full stop.

In the SURMOUNT-1 trial, which randomised over 2,500 adults with obesity and reported results in the New England Journal of Medicine, the substantial weight reductions seen at 15 mg (around 20–21% of body weight on average) built up over 72 weeks of dose escalation. Nobody arrived there in week four. Expecting the needle to move at 2.5 mg is a bit like judging a car's speed during warm-up. The question worth sitting with is not whether 2.5 mg is working, but whether you are on track to step up at the right time.

One checking habit worth building: before each weekly injection, note your current dose and when you started it. A quick glance at those two things tells you whether a step-up conversation with your prescriber is due, takes about thirty seconds and means you never drift through extra weeks at a dose that was only ever meant to be temporary.

What happens to appetite and weight as the dose increases

Tirzepatide works by activating two gut-hormone receptors (GIP and GLP-1) that signal fullness and slow the rate at which food leaves your stomach. At 2.5 mg, that effect is mild. Many people notice little change in hunger. As the dose rises through 5 mg, 7.5 mg and beyond, the appetite-suppressing signal strengthens, and that is when most people begin eating less without consciously trying.

If you are already at 5 mg and still not seeing movement, the picture is different, there is a separate page covering why weight loss can stall at 5 mg with its own set of factors. At 2.5 mg, the honest answer is simpler: the dose is not yet high enough to produce the effect the medicine is capable of.

The NHS medicines page for tirzepatide describes the dose escalation schedule clearly, and it is worth reading before your first or second pen arrives so you know what to expect at each stage.

Other things that can work against you even at higher doses, worth knowing now

It is worth thinking about these factors early, because they compound. Diet quality matters even when appetite falls. Tirzepatide reduces hunger, but if the food you are eating is very calorie-dense, the appetite signal alone may not create the deficit needed. Protein adequacy, fibre and hydration all affect how the medicine feels to live with day-to-day.

Sleep and stress have a measurable impact on weight regulation, independent of what you eat. Certain medications (some antidepressants, corticosteroids, insulin and others) can blunt weight loss, and your prescriber should know about everything you take. If you are on hormonal contraception, there is a specific interaction worth flagging: women taking the oral contraceptive pill should use an additional method of contraception for the first four weeks on tirzepatide and after each dose increase, because tirzepatide may reduce pill absorption. That is an NHS England recommendation, not a minor footnote, and it is worth checking our clinical FAQs if you have questions about it.

For a broader picture of the different factors that affect progress across the full dose range, the Mounjaro treatment overview pulls together what the clinical evidence says about who responds and when.

When to talk to your prescriber, and what that conversation looks like

At 2.5 mg with no weight change and no side effects, the most useful conversation with your prescriber is about timing: are you ready to step up, and when? That is a clinical call based on your tolerance, your starting weight, any conditions you have and how your body has responded so far. Prescribers do not expect you to have lost weight at this stage, but they do want to know how you are feeling physically.

If you have been on 2.5 mg for longer than the planned four weeks with no clinical reason to hold the dose, that is worth raising directly. Equally, if side effects have been significant, staying at 2.5 mg a little longer is reasonable and your prescriber can advise. As you move through the schedule, it is also useful to know that there are dedicated pages explaining why weight loss can stall at 7.5 mg, what can hold progress back at 12.5 mg, and why some people do not lose weight even at the 15 mg dose, so you have somewhere to turn at each stage. The point is that the plan should be active, not static.

Understanding the cost of Mounjaro over time is worth doing at this stage too, so the financial picture is clear as you move through the dose schedule. And if you are considering what full treatment looks like from here, our treatment page sets out how a nume consultation works, step by step. A prescriber reviews every case individually, speak to our prescribers if you have concerns about your current dose or your progress so far.